GLORIA

GEOMAR Library Ocean Research Information Access

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
Document type
Language
  • 1
    Online Resource
    Online Resource
    San Diego :Elsevier Science & Technology,
    Keywords: Renewable energy sources. ; Electronic books.
    Type of Medium: Online Resource
    Pages: 1 online resource (221 pages)
    Edition: 1st ed.
    ISBN: 9780128052907
    DDC: 333.9539
    Language: English
    Note: Front Cover -- Developing the Global Bioeconomy -- Copyright Page -- Dedication -- Disclaimer -- Contents -- List of Figures -- List of Contributors -- Biography -- Preface -- Acknowledgments -- 1 Bioeconomy Strategies -- 1.1 Introduction -- 1.2 Status of Bioeconomy Strategies in IEA Bioenergy Member Countries -- 1.3 Scope, Objective, and Outline -- References -- 2 Development of Second-Generation Biorefineries -- 2.1 Introduction -- 2.2 Technology and Feedstock Matrix -- 2.2.1 Composting and Anaerobic Digestion -- 2.2.2 Preprocessing Technologies -- 2.2.2.1 Basic Biomass Preprocessing Methods -- 2.2.2.2 Densification and Thermal Pretreatment -- 2.2.3 Pretreatment: Physical, Chemical, and Biochemical -- 2.2.4 Saccharification of Cellulose and Hemicellulose -- 2.2.5 (Bio)-Catalytic Production of Bioethanol and Various Chemicals -- 2.2.5.1 Chemicals From Glycerol -- 2.2.6 Thermochemical Conversion: Fast Pyrolysis -- 2.2.6.1 Fast Pyrolysis Reactors -- 2.2.6.2 Pyrolysis Liquid: Bio-Oil -- 2.2.6.3 Bio-Oil Characteristics -- 2.2.6.4 Applications of Bio-Oil -- 2.3 Summary -- References -- 3 Biorefineries: Industry Status and Economics -- 3.1 Introduction -- 3.2 Economics -- 3.2.1 Economic Considerations -- 3.2.1.1 Factorial Method -- 3.2.1.2 Step Accounting Method -- 3.2.1.3 Exponential Method -- 3.2.2 Economic Lessons Learned From Bioethanol and Bio-Oil Derived From Lignocellulosic Biomass -- 3.3 Demonstration and Full-Scale Plants -- 3.3.1 Fast Pyrolysis: Current Status -- 3.3.1.1 Ensyn Corp (ENSYN, 2014) -- 3.3.1.2 KIT (Bioliq) -- 3.3.1.3 Fortum -- 3.3.1.4 BTG BioLiquids BV -- 3.3.1.5 EMPYRO -- 3.3.2 Biochemical Conversion -- 3.3.2.1 Bioethanol Production -- 3.3.3 Biorefineries: Starch/Sugar-Based -- 3.4 Summary and Outlook -- References -- 4 Sustainability Considerations for the Future Bioeconomy -- 4.1 Introduction. , 4.2 Overview of Methodologies and Sustainability Assessment Frameworks -- 4.3 Lessons Learned From First-Generation Biofuels and Bioenergy Crops -- 4.4 Sustainability Assessment Challenges -- 4.5 Considerations for Future Assessments in the Bioeconomy Sector -- 4.6 Conclusions and Recommendations -- References -- 5 Biomass Supply and Trade Opportunities of Preprocessed Biomass for Power Generation -- 5.1 Introduction -- 5.1.1 Biomass Supply and Demand Centers -- 5.2 International Trade and Supply Opportunities of Processed Stable Biomass Intermediates for Biopower Market -- 5.2.1 Development of Biopower Markets -- 5.2.2 The Importance of Preprocessing -- 5.2.2.1 Pelleting and Torrefaction -- 5.2.2.2 Hydrothermal Carbonization -- 5.2.3 Location of Final Conversion Facility -- 5.2.4 Energy Crop-Based Supply Chains: Mozambique Case Study -- 5.3 Local/Regional Trade and Supply Opportunities of Raw Biomass for Bioenergy Market -- 5.3.1 Agricultural Residues-Based Supply Chains: South Africa Case Study -- 5.3.1.1 Corn and Wheat Residue Costs at the Farm Gate -- 5.3.1.2 Crop Residue Costs Delivered at the Conversion Plant -- 5.4 Conclusions -- References -- 6 Commodity-Scale Biomass Trade and Integration with Other Supply Chains -- 6.1 Introduction -- 6.2 Evolution of Commoditized Biomass -- 6.3 Current Commodity-Scale Biomass Trade -- 6.4 The Integration of Commoditized Biomass With Other Commodity Supply Chains -- 6.4.1 Leveraging Solids Handling Infrastructure -- 6.4.1.1 Case Study 1: Conventional and Torrefied Wood Pellets -- 6.4.1.2 Case Study 2: Residue Bundling System Integration With Forest Industry in Finland -- 6.4.1.3 Case Study 3: Shipping of Forest Biomass Over the Baltic Sea -- 6.4.2 Leveraging Liquids Handling Infrastructure -- 6.4.3 Leveraging Gas Handling Infrastructure -- 6.5 Future Trends, Recommendation, and Conclusion -- References. , 7 Commoditization of Biomass Markets -- 7.1 Introduction -- 7.1.1 From Bioenergy to Bioeconomy -- 7.1.2 Commoditization of Biomass Markets -- 7.2 Defining "Commodities" -- 7.2.1 Properties of the Good Itself -- 7.2.2 Market-Related Properties -- 7.2.3 Futures Contracts: A Sign of Advanced Commoditization -- 7.3 Commoditization Example: The Case of the Crude Oil Market -- 7.3.1 The Commoditization of the Crude Oil Market From 1973 to 1987 -- 7.3.2 Analysis -- 7.4 Commoditization of Biomass Markets -- 7.4.1 "Intermediate Goods": What Is the Commodity Used For? -- 7.4.2 Fungibility, Homogeneity, and Standardization -- 7.4.2.1 Product Quality -- 7.4.2.2 Commoditization, Sustainability, and Traceability -- 7.4.3 Market Structure -- 7.4.4 Market Liquidity -- 7.4.5 International Market Integration -- 7.4.6 Conclusions -- 7.5 Biomass Commoditization: The Way Forward -- 7.5.1 Futures Contract Failure: A Sign of Market Immaturity -- 7.5.2 The Road to Commoditization -- 7.5.2.1 Commoditization: Good for the Market but Not for All Market Actors? -- 7.5.2.2 Policy-Related Obstacles to Biomass Commoditization -- 7.5.2.3 Market-Related Obstacles to Biomass Commoditization -- Acknowledgment -- References -- 8 Transition Strategies: Resource Mobilization Through Merchandisable Feedstock Intermediates -- 8.1 Objective and Link to Previous Chapters -- 8.2 Challenges Within Large-Scale Biorefinery Feedstock Supply Chains -- 8.3 Feedstock Supply System Types: Conventional and Advanced -- 8.4 Depot Configurations and Evolvement -- 8.4.1 Early-Stage Depots -- 8.4.2 Later-Stage Depots -- 8.5 Depot Deployment -- 8.5.1 Overcoming the Mobilization Gridlock via Merchandisable Intermediates for Multiple Markets -- 8.5.2 Separating the Vertical Supply Chain -- 8.6 Market Transition -- 8.6.1 Transition Periods -- 8.6.2 Supply Chain Opportunities -- 8.7 Conclusions -- References. , Conclusions -- Introduction -- Scope -- Lessons From Bioenergy -- References -- Index -- Back Cover.
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    [Erscheinungsort nicht ermittelbar] : IEA Bioenergy
    Keywords: Forschungsbericht
    Type of Medium: Online Resource
    Pages: 1 Online-Ressource (60 Seiten, 2.516 KB) , Illustrationen, Diagramme, Karten
    Language: English
    Note: Literaturangaben
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1471-4159
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: The ability of cells to control the balance between the generation and quenching of reactive oxygen species is important in combating potentially damaging effects of oxidative stress. One mechanism that cells use to maintain redox homeostasis is the antioxidant response pathway. Antioxidant response elements (AREs) are cis-acting elements located in regulatory regions of antioxidant and phase II detoxification genes. Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) is a member of the Cap ‘n’ Collar family of transcription factors that binds to the ARE and regulates the transcription of specific ARE-containing genes such as NAD(P)H:quinone oxidoreductase 1, glutamylcysteine synthetase and heme oxygenase. Activation of Nrf2 results in release from its negative repressor, Kelch-like ECH-associated protein 1 (Keap1), and allows Nrf2 to translocate into the nucleus to induce gene expression. In this study, we demonstrate that increasing Nrf2 activity by various methods, including chemical induction, Nrf2 overexpression or Keap1 siRNA knockdown, protects cells against specific types of oxidative damage. Cells were protected against 6-hydroxydopamine- and 3-morpholinosydnonimine-mediated toxicity but not against 1-methyl-1-4-phenylpyridinium toxicity. As oxidative stress is a hallmark of several neurodegenerative disorders, including Parkinson's disease, pharmacological agents that selectively target the Keap1-Nrf2 pathway may provide a novel neuroprotective strategy for the treatment of these diseases.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Palo Alto, Calif. : Annual Reviews
    Annual Review of Fluid Mechanics 22 (1990), S. 255-274 
    ISSN: 0066-4189
    Source: Annual Reviews Electronic Back Volume Collection 1932-2001ff
    Topics: Mechanical Engineering, Materials Science, Production Engineering, Mining and Metallurgy, Traffic Engineering, Precision Mechanics , Physics
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    College Park, Md. : American Institute of Physics (AIP)
    The Journal of Chemical Physics 113 (2000), S. 9353-9354 
    ISSN: 1089-7690
    Source: AIP Digital Archive
    Topics: Physics , Chemistry and Pharmacology
    Notes: This recent paper uses multiconfiguration self-consistent field (MCSCF) wave functions to study the structure of Si(001). The results are at odds with density functional theory predictions and experiment. This comment shows that dynamic correlation, which is neglected in MCSCF calculations, is essential for reliable predictions of the geometry of Si(001). © 2000 American Institute of Physics.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    ISSN: 1365-2516
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Summary. Fibrin sealant, which consists mainly of fibrinogen and thrombin, provides rapid haemostasis as well as tissue sealing and adhesion. Commercial, viralinactivated products are available in Europe, Canada, and Japan. Liquid fibrin sealant (LFS) has been used clinically in haemophiliacs to perform dental procedures, orthopedic surgeries, non-orthopaedic surgeries, and circumcisions. LFS use is expected to increase as commercial products will soon be available in the US. Recombinant sources and transgenic animal bioreactor systems will replace plasma-derived products and become the predominant sources for this product in the next decade. Other areas of innovation include the development of fibrin sealant bandages or dressings, expandable foams, and spray powders which will provide the haemophiliac the ability to rapidly attain control of traumatic haemorrhages prior to hospital treatment with a significant reduction in the use of IV clotting factors. Fibrin sealant products have the potential to provide life-saving control of haemorrhage, reduction in factor dependency, lower viral exposure risk, and medical care cost reduction.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Clinical & experimental allergy 23 (1993), S. 0 
    ISSN: 1365-2222
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Clinical & experimental allergy 27 (1997), S. 0 
    ISSN: 1365-2222
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Background Corticosteroid therapy has become the mainstay in the treatment of asthma. However, the risk-benefit balance in the patient calls for assessment of the state of inflammation in the airways. In this respect serum eosinophil cationic protein (ECP) might be a marker, which can easily be measured in a clinical setting. Studies have indicated a relation between level of serum ECP and activity and severity in asthma.Objective To investigate the feasibility to guide steroid therapy on the basis of the level of serum ECP in patients with chronic asthma.Methods Twenty adult patients on maintenance inhaled steroid therapy visited the chest clinic once every 2 months over a 12-month period. At each visit a short history, blood sample for ECP and number of eosinophils, baseline spirometry, and histamine inhalation provocation test (PC20) were obtained. On the basis of level of ECP, adjustments in daily dose of steroids were considered. Data were compared with those of a previous 6-month ECP evaluation study in these same patients.Results In 10 patients mean dose of inhaled steroids was decreased 〈inlineGraphic alt="geqslant R: gt-or-equal, slanted" extraInfo="nonStandardEntity" href="urn:x-wiley:09547894:CEA519:ges" location="ges.gif"/〉 25%. ECP rose slightly (antilogged mean from 9.06 to 11.8μg/L) and lung function decreased slightly (mean FEV1%predicted from 85.5 to 81.6). In seven patients mean dose of inhaled or oral (n= 2) steroids was increased 〈inlineGraphic alt="geqslant R: gt-or-equal, slanted" extraInfo="nonStandardEntity" href="urn:x-wiley:09547894:CEA519:ges" location="ges.gif"/〉 25%. In this group ECP decreased but remained elevated at 〈inlineGraphic alt="geqslant R: gt-or-equal, slanted" extraInfo="nonStandardEntity" href="urn:x-wiley:09547894:CEA519:ges" location="ges.gif"/〉20μg/L (antilogged mean from 30.5 to 25.6μg/L) and lung function improved (mean FEV1%predicted from 67.2 to 74.5). In both groups patients' scores of asthmatic well-being increased significantly, and PC20 did not show a trend. Exacerbation rate remained the same in the decreased and the no change group (n= 3, in which no substantial change in steroid dose occurred), but was reduced by about 50% in the increased group.Conclusion From this observational study it is concluded that adjusting steroid therapy guided by serum ECP-level may be helpful in tailoring asthma treatment.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Science Ltd
    Clinical & experimental allergy 34 (2004), S. 0 
    ISSN: 1365-2222
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Electronic Resource
    Electronic Resource
    Oxford, UK : Blackwell Publishing Ltd
    Allergy 45 (1990), S. 0 
    ISSN: 1398-9995
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Sera from 204 adult patients with chronic airways obstruction were analysed with the Phadiatop®, a new allergosorbent test with a paper disc containing the most relevant inhalant allergens, the PRIST for total IgE determinations, and a panel of seven RAST tests with the common inhalant allergens in The Netherlands as reference. The aim was to evaluate the Phadiatop as screening test in the in vitro diagnostic procedures in an epidemiological setting. The Phadiatop was classified positive or negative according to percentage binding, total IgE was considered elevated at values 〉 100 kU/1 and the RAST panel positive when at least one RAST result was class 〉 1. The prevalence of inhalant atopy came to 27.9%. The predictive value of the Phadiatop for a positive RAST panel was 96.4%, and for a negative RAST panel 97.3%. For the PRIST these values were 51.9% and 87.2% respectively. The correlation between the log percentages binding of the Phadiatop and the RAST panel was 0.93. It is concluded that the Phadiatop is a valuable test for the screening of inhalant atopy, and as the percentage binding of the Phadiatop may reflect the degree of sensitization it could also be applied as a quantitative measure especially for epidemiological purposes.
    Type of Medium: Electronic Resource
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...